Superhydrophobic membranes for clean water production
The project aims to develop superhydrophobic membranes for membrane distillation to produce clean water from industrial waste, addressing water scarcity and pollution while enabling commercial applications.
Projectdetails
Introduction
Our world faces an urgent need for a greener industry with reduced water consumption and zero pollution, alleviating water scarcity problems. Membrane distillation (MD) is being explored for the production of clean water from industrial waste streams in the steel, textile, food, and other industries.
Challenges
Several challenges need to be overcome to achieve a full commercial market breakthrough for MD:
- Membrane wetting
- Scaling
- Fouling
Proposed Solution
We plan to accept the challenges by using superhydrophobic membranes. Such membranes are also useful in oil-water separation and a range of environmental applications.
Collaborative Efforts
During the FET HARMONIC project, two RORs, Max Planck-MPIP and NCSR-Demokritos, developed complementary technologies for membrane superhydrophobicity, which impart extreme antiwetting, antiscaling, and antifouling properties. The technologies are based on:
- Plasma activation or plasma nanotexturing (NCSRD)
- Wet nanofilament growth (MPIP)
- Plasma deposition (NCSRD) for hydrophobization
Both institutions will advance their technology readiness level so the technology is validated and demonstrated in a relevant environment (TRL 5-6). They will design, build, and test small-scale pilot equipment for fabricating rolls of superhydrophobic membranes in a roll-to-roll format.
Industrial Collaboration
For the upscaling of the technology, NCSRD and MPIP will cooperate with two industrial partners:
- Europlasma
- SolSep
These companies have large experience with roll-to-roll plasma or wet processes, respectively. Moreover, they will team up with Aquastill, a manufacturer of commercial MD modules for industrial wastewater treatment.
Market Development
A market search and a business plan will be elaborated for creating a spin-off company that will commercialize the superhydrophobic membranes and processes. The range of applications will go well beyond MD.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.497.750 |
Totale projectbegroting | € 2.497.750 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 30-6-2026 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- "NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""penvoerder
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
- SOLARSPRING GMBH
- EUROPLASMA NV
- SOLSEP BV
- AQUASTILL BV
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Sustainable and HIgh Performance MEmbranes via iNTerfacial complexation (SHIPMENT)This project aims to enhance the water permeability of sustainable polyelectrolyte complex membranes by modifying the Aqueous Phase Separation technique with Interfacial Complexation for improved industrial viability. | ERC POC | € 150.000 | 2022 | Details |
Building charge-MOSAIC nanofiltration membranes for removing micro-pollutants from surface and drinking waterThis project aims to develop scalable charge-mosaic membranes using polyelectrolyte multilayers to efficiently remove organic micropollutants from water while minimizing energy use and waste. | ERC COG | € 2.000.000 | 2023 | Details |
Sustainable Plasmonic Membranes for Water RemediationThe SusPlasMem project aims to develop a sustainable plasmonic membrane for efficient degradation of pharmaceutical micropollutants in wastewater using visible light. | ERC POC | € 150.000 | 2024 | Details |
BIOmimetic selective extraction MEMbranesBIOMEM aims to create energy-efficient biomimetic membranes using biological transport proteins for selective extraction of valuable compounds and pollutants from water. | EIC Pathfinder | € 2.119.133 | 2024 | Details |
Sustainable and HIgh Performance MEmbranes via iNTerfacial complexation (SHIPMENT)
This project aims to enhance the water permeability of sustainable polyelectrolyte complex membranes by modifying the Aqueous Phase Separation technique with Interfacial Complexation for improved industrial viability.
Building charge-MOSAIC nanofiltration membranes for removing micro-pollutants from surface and drinking water
This project aims to develop scalable charge-mosaic membranes using polyelectrolyte multilayers to efficiently remove organic micropollutants from water while minimizing energy use and waste.
Sustainable Plasmonic Membranes for Water Remediation
The SusPlasMem project aims to develop a sustainable plasmonic membrane for efficient degradation of pharmaceutical micropollutants in wastewater using visible light.
BIOmimetic selective extraction MEMbranes
BIOMEM aims to create energy-efficient biomimetic membranes using biological transport proteins for selective extraction of valuable compounds and pollutants from water.